drugset / Trial / NCT02498535
Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients
Phase 2
Terminated
49 enrolled
Novoteris, LLC
Cystic Fibrosis Foundation · collabMallinckrodt · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Prospective, randomized, placebo controlled, phase II clinical study of subjects crossing over from an approved inhaled antibiotic to inhaled nitric oxide as compared to a placebo control arm.
Timeline
- Start
- 2017-02-22
- Primary completion
- 2020-06-01
- Completion
- 2020-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitric Oxide | Other / unclassified | 160 ppm | Inhaled |